Perceptions of natural health products among patients attending a memory clinic

American Journal of Alzheimer's Disease and other Dementias

Volumn 21, Issue 3, 2006, Pages 156-163

  Sharma, Papita ^a   Herrmann, Nathan ^a   Rochon, Paula A ^a   Lee, Monica ^a   Croxford, Ruth ^a   Rothenburg, Lana ^a   Black, Sandra E ^a   Lanctôt, Krista L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Dementia; Natural health products (NHPs); NHP efficacy perceptions; NHP safety perceptions; NHP drug interactions; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHONDROITIN; ECHINACEA EXTRACT; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLUCOSAMINE; GLUCOSAMINE SULFATE; HYPERICUM PERFORATUM EXTRACT; MELATONIN; NATURAL PRODUCT; PRIMROSE OIL; VALERIAN; ZINC;

ADULT; AGED; ARTICLE; CAREGIVER; COGNITIVE DEFECT; CONSUMER ATTITUDE; DEMENTIA; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; FLOWER; GINKGO BILOBA; HEALTH BELIEF; HUMAN; HUMAN EXPERIMENT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MULTIVARIATE ANALYSIS OF VARIANCE; NORMAL HUMAN; PASSION FRUIT; PATIENT ATTITUDE; PATIENT COUNSELING; SELF REPORT; UNIVARIATE ANALYSIS;

EID: 33745929351     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317506289351     Document Type: Article

References (42)

1. Scott GN, Elmer GW. Update on natural product-drug interactions. Am J Health-Syst Pharm. 2002;59:339-347.
2. Berger E. Berger Population Health Monitor. Toronto, Canada: Hay Associates; 2002.
3. Dietary Supplement Health and Education Act of 1994, S784, 103rd congress, 2nd session, January 25, 1994. Available at: http: //frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=103_cong_bills&docid=f: s784enr .txt.pdf.
4. Gugliotta G. Health concerns grow over herbal aids. Available at: http://washingtonpost.com/wp-dn/articles/a32685-2000mar17.html. Accessed September 20, 2000.
5. Bruyn TD. A Summary of National Data on Complementary and Alternative Health Care-Current Status and Future Development: A Discussion Paper. Available at: www.hc-sc.gc.ca/hpfb-dgpsa/nhpd-dpsn/summary_national_data_cahc_2_e.html.
6. Harnack EJ, DeRosier KE, Rydell SA. Results of a population-based survey of adults' attitudes and beliefs about herbal products. J Am Pharma Assoc. 2003;43:596-601.
7. Falkenberg T, Sawyer J, Zhang X, et al. World Health Organization Traditional Medicine Strategy 2002-2005. Available at: http://www.who.int/ medicines/library/trm/strategytrm.shtml. Accessed February 14, 2005.
8. Dergal JM, Gold JE, Eaxer DA, et al. Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging. 2002;19:879-886.
9. Brazier NC, Levine MA. Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am J Ther. 2003;10:163-169.
10. Gold JL, Laxer DA, Rochon PA. Herbal remedies: a critical perspective. Ann R Coll Physicians Surg Canada. 2000;33:497.
11. Ott BR, Owens NJ. Complementary and alternative medicines for Alzheimer's disease. J Geriatr Psychiatry Neurology. 1998;11:163-173.
12. Boullata JI, Nace AM. Safety issues with herbal medicine. Pharmacotherapy. 2000;20:257-269.
13. Saper RB, Kales SN, Paquin J, et al. Heavy metal content of ayurvedic herbal medicine products. J Am Med Assoc. 2004;292:2868-2873.
14. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. J Am Med Assoc. 1998;280:1569-1575.
15. Klepser TB, Doucette WR, Horton MR, et al. Assessment of patients' perceptions and beliefs regarding herbal therapies. Pharmacotherapy. 2000;20:83-87.
16. Desai AK. Herbals and botanicals in geriatric psychiatry. Am J Geriatr Psychiatry. 2003;11:498-506.
17. Giveon SM, Liberman N, Klang S, Kahan E. A survey of primary care physicians' perceptions of their patients' use of complementary medicine. Complement Ther Med. 2003;11:254-260.
18. Gold JL, Laxer DA, Dergal JM, et al. Herbal-drug therapy interactions: a focus on dementia. Curr Opin Clin Nutr Metab Care. 2001;4:29-34.
19. Coleman LM, Fowler LL, Williams ME. Use of unproven therapies by people with Alzheimer's disease. J Am Geriatr Soc. 1995;43:747-750.
20. Hogan DB, Ebly EM. Complementary medicine use in a dementia clinic population. Alzheimer Dis Assoc Disord. 1996;10:63-67.
21. Chandler F. Herbs: Everyday Reference for Health Professionals. Ottawa: Canadian Pharmacists Association and Canadian Medical Association; 2000.
22. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res. 1975;12:189-198.
23. Bucks RS, Ashworth DL, Wilcock GK, Siegfried K. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing. 1996;25:113-120.
24. Gelinas I, Gauthier L, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther. 1999;53:471-481.
25. Galasko D, Bennett D, Sano M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease: the Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11(suppl 2):S33-S39.
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
27. McDowell M, Hill G, Lindsay J, et al. Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc J. 1994;150:899-913.
28. Bennett J, Brown CM. Use of herbal remedies by patients in a health maintenance organization. J Am Pharm Assoc. 2000;40:353-358.
29. Wagner PJ, Jester D, LeClair B, et al. Taking the edge off: why patients choose St. John's Wort. J Fam Pract. 1999;48:615-619.
30. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997;336:1216-1222.
31. Behl C, Davis J, Cole GM, Schubert D. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Comm. 1992;186:944-950.
32. Kappus H, Diplock AT. Tolerance and safety of vitamin E: a lexicological position report. Free Rad Biol Med. 1992;13:55-74.
33. Sano M, Ernesto C, Klauber MR, et al. Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1996;10:132-140.
34. Rabbins P, Blacker D, Bland W, et al. Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias of Late Life. Washington, DC: American Psychiatric Association; 1997.
35. Prasad K, Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J. 1993;125:958-973.
36. Parker RA, Sabrah T, Cap M, Gill BT. Relation of vascular oxidative stress, alpha-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters. Arterioscler Thromb Vasc Biol. 1995;15:349-358.
37. Crawford RS, Kirk EA, Rosenfeld ME, et al. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol. 1998;18:1506-1513.
38. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr. 1996;64:190-196.
39. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
40. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
41. Vivekananthan DP, Penn MS, Sapp SK, et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361:2017-2023.
42. Miller ER, III, Pastor-Barriuso R, Dalai D, et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46.